SK280244B6 - Kompozícia na použitie pri indukcii spojenia medzi - Google Patents

Kompozícia na použitie pri indukcii spojenia medzi Download PDF

Info

Publication number: SK280244B6
Authority: SK; Slovakia
Prior art keywords: composition; enamel matrix; protein fraction; enamel; protein
Prior art date: 1988-03-17

Application number

SK1637-89A

Other languages

English (en)

Slovak (sk)

Other versions

SK163789A3 (en

Inventor

Lars Hammrstr�M

Leif Bloml�F

Sven Lindskog

Original Assignee

Bioventures B.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-03-17

Filing date

1989-03-16

Publication date

1999-10-08

1989-03-16 Application filed by Bioventures B.V. filed Critical Bioventures B.V.

1999-10-08 Publication of SK163789A3 publication Critical patent/SK163789A3/sk

1999-10-08 Publication of SK280244B6 publication Critical patent/SK280244B6/sk

Links

102000004169 proteins and genes Human genes 0.000 title claims abstract description 65
108090000623 proteins and genes Proteins 0.000 title claims abstract description 65
239000000203 mixture Substances 0.000 title claims abstract description 42
230000001939 inductive effect Effects 0.000 title claims abstract description 8
238000000034 method Methods 0.000 title claims description 21
239000008194 pharmaceutical composition Substances 0.000 title claims description 5
238000002360 preparation method Methods 0.000 title description 7
230000008569 process Effects 0.000 title description 6
210000003298 dental enamel Anatomy 0.000 claims abstract description 63
239000011159 matrix material Substances 0.000 claims abstract description 54
201000001245 periodontitis Diseases 0.000 claims abstract description 16
239000002243 precursor Substances 0.000 claims abstract description 13
239000003085 diluting agent Substances 0.000 claims abstract description 10
244000052616 bacterial pathogen Species 0.000 claims abstract description 8
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
239000000853 adhesive Substances 0.000 claims abstract description 7
230000001070 adhesive effect Effects 0.000 claims abstract description 7
201000010099 disease Diseases 0.000 claims abstract description 7
238000004519 manufacturing process Methods 0.000 claims abstract description 7
230000008929 regeneration Effects 0.000 claims abstract description 5
238000011069 regeneration method Methods 0.000 claims abstract description 5
210000001080 enamel organ Anatomy 0.000 claims abstract description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 51
108010007570 Amelogenin Proteins 0.000 claims description 17
102000007325 Amelogenin Human genes 0.000 claims description 17
239000004480 active ingredient Substances 0.000 claims description 13
241000282887 Suidae Species 0.000 claims description 6
239000003814 drug Substances 0.000 claims description 6
241000283690 Bos taurus Species 0.000 claims description 5
235000010443 alginic acid Nutrition 0.000 claims description 5
229920000615 alginic acid Polymers 0.000 claims description 5
229920003169 water-soluble polymer Polymers 0.000 claims description 5
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 4
229940072056 alginate Drugs 0.000 claims description 4
239000001913 cellulose Substances 0.000 claims description 4
229920002678 cellulose Polymers 0.000 claims description 4
238000000605 extraction Methods 0.000 claims description 4
230000001172 regenerating effect Effects 0.000 claims description 3
239000003292 glue Substances 0.000 claims description 2
230000017423 tissue regeneration Effects 0.000 claims description 2
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
238000002955 isolation Methods 0.000 claims 1
241000124008 Mammalia Species 0.000 abstract description 6
239000013543 active substance Substances 0.000 abstract 1
239000000470 constituent Substances 0.000 abstract 1
210000000246 tooth germ Anatomy 0.000 abstract 1
235000018102 proteins Nutrition 0.000 description 51
210000001519 tissue Anatomy 0.000 description 23
239000000126 substance Substances 0.000 description 16
230000035876 healing Effects 0.000 description 14
210000000988 bone and bone Anatomy 0.000 description 13
239000003479 dental cement Substances 0.000 description 11
230000006378 damage Effects 0.000 description 10
239000000284 extract Substances 0.000 description 10
239000000047 product Substances 0.000 description 10
239000000835 fiber Substances 0.000 description 8
102100040409 Ameloblastin Human genes 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
210000000981 epithelium Anatomy 0.000 description 7
241000894006 Bacteria Species 0.000 description 6
102000008186 Collagen Human genes 0.000 description 6
108010035532 Collagen Proteins 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
239000004568 cement Substances 0.000 description 6
229920001436 collagen Polymers 0.000 description 6
230000003239 periodontal effect Effects 0.000 description 6
210000004746 tooth root Anatomy 0.000 description 6
241001465754 Metazoa Species 0.000 description 5
208000027418 Wounds and injury Diseases 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000002244 precipitate Substances 0.000 description 5
235000002639 sodium chloride Nutrition 0.000 description 5
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
238000001356 surgical procedure Methods 0.000 description 5
238000012360 testing method Methods 0.000 description 5
210000000689 upper leg Anatomy 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
241000282693 Cercopithecidae Species 0.000 description 4
241000700159 Rattus Species 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
238000009826 distribution Methods 0.000 description 4
230000000694 effects Effects 0.000 description 4
108010074702 enamel matrix proteins Proteins 0.000 description 4
238000009472 formulation Methods 0.000 description 4
239000007943 implant Substances 0.000 description 4
210000000214 mouth Anatomy 0.000 description 4
239000000243 solution Substances 0.000 description 4
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
108010071289 Factor XIII Proteins 0.000 description 3
108010049003 Fibrinogen Proteins 0.000 description 3
102000008946 Fibrinogen Human genes 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
101000891247 Homo sapiens Ameloblastin Proteins 0.000 description 3
HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
108090000190 Thrombin Proteins 0.000 description 3
206010052428 Wound Diseases 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
150000001720 carbohydrates Chemical class 0.000 description 3
235000010980 cellulose Nutrition 0.000 description 3
238000001816 cooling Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
229940012444 factor xiii Drugs 0.000 description 3
229940012952 fibrinogen Drugs 0.000 description 3
239000000499 gel Substances 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
230000004054 inflammatory process Effects 0.000 description 3
210000004261 periodontium Anatomy 0.000 description 3
235000010409 propane-1,2-diol alginate Nutrition 0.000 description 3
239000000770 propane-1,2-diol alginate Substances 0.000 description 3
239000011347 resin Substances 0.000 description 3
229920005989 resin Polymers 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
238000003756 stirring Methods 0.000 description 3
229960004072 thrombin Drugs 0.000 description 3
238000002054 transplantation Methods 0.000 description 3
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
108010039627 Aprotinin Proteins 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
229920002907 Guar gum Polymers 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
206010037464 Pulpitis dental Diseases 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
229960004405 aprotinin Drugs 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
239000008112 carboxymethyl-cellulose Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
210000002808 connective tissue Anatomy 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
210000004268 dentin Anatomy 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
239000000665 guar gum Substances 0.000 description 2
235000010417 guar gum Nutrition 0.000 description 2
229960002154 guar gum Drugs 0.000 description 2
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
208000014674 injury Diseases 0.000 description 2
230000007774 longterm Effects 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
238000011160 research Methods 0.000 description 2
235000010413 sodium alginate Nutrition 0.000 description 2
239000000661 sodium alginate Substances 0.000 description 2
229940005550 sodium alginate Drugs 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
239000003106 tissue adhesive Substances 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
241000009355 Antron Species 0.000 description 1
108010039209 Blood Coagulation Factors Proteins 0.000 description 1
102000015081 Blood Coagulation Factors Human genes 0.000 description 1
241001609030 Brosme brosme Species 0.000 description 1
208000027205 Congenital disease Diseases 0.000 description 1
208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 1
208000006558 Dental Calculus Diseases 0.000 description 1
206010063560 Excessive granulation tissue Diseases 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
108091007369 NEUR proteins Proteins 0.000 description 1
102100030466 Neurocan core protein Human genes 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241001319148 Pharmacis Species 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
208000002847 Surgical Wound Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
238000010171 animal model Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000033558 biomineral tissue development Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
239000003114 blood coagulation factor Substances 0.000 description 1
244000309466 calf Species 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001055 chewing effect Effects 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
210000000078 claw Anatomy 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
235000021438 curry Nutrition 0.000 description 1
230000007547 defect Effects 0.000 description 1
239000004053 dental implant Substances 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000000921 elemental analysis Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
-1 for example Chemical compound 0.000 description 1
230000006870 function Effects 0.000 description 1
210000001126 granulation tissue Anatomy 0.000 description 1
230000012010 growth Effects 0.000 description 1
210000004394 hip joint Anatomy 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
230000007124 immune defense Effects 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
210000004969 inflammatory cell Anatomy 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
238000007689 inspection Methods 0.000 description 1
238000005304 joining Methods 0.000 description 1
239000012931 lyophilized formulation Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
101150006061 neur gene Proteins 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000004584 polyacrylic acid Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
235000004252 protein component Nutrition 0.000 description 1
238000002601 radiography Methods 0.000 description 1
230000000979 retarding effect Effects 0.000 description 1
230000021749 root development Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000003307 slaughter Methods 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000010257 thawing Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
229940033618 tisseel Drugs 0.000 description 1
230000009772 tissue formation Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0005—Ingredients of undetermined constitution or reaction products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
Developmental Biology & Embryology (AREA)
Zoology (AREA)
Surgery (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oral & Maxillofacial Surgery (AREA)
Organic Chemistry (AREA)
Dental Preparations (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Adhesives Or Adhesive Processes (AREA)
Curing Cements, Concrete, And Artificial Stone (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

SK1637-89A 1988-03-17 1989-03-16 Kompozícia na použitie pri indukcii spojenia medzi SK280244B6 (sk)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE8800980A SE461313B (sv)	1988-03-17	1988-03-17	Bindningsinducerande komposition

Publications (2)

Publication Number	Publication Date
SK163789A3 SK163789A3 (en)	1999-10-08
SK280244B6 true SK280244B6 (sk)	1999-10-08

Family

ID=20371730

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1637-89A SK280244B6 (sk)	1988-03-17	1989-03-16	Kompozícia na použitie pri indukcii spojenia medzi

Country Status (29)

Country	Link
US (2)	US5071958A (cs)
EP (1)	EP0337967B1 (cs)
JP (1)	JP2795667B2 (cs)
KR (1)	KR0175138B1 (cs)
CN (1)	CN1034630C (cs)
AT (1)	ATE89156T1 (cs)
AU (1)	AU613161B2 (cs)
CA (1)	CA1339338C (cs)
CZ (1)	CZ284330B6 (cs)
DD (2)	DD281116A5 (cs)
DE (1)	DE68906455T2 (cs)
DK (1)	DK175731B1 (cs)
ES (1)	ES2055159T3 (cs)
FI (1)	FI90011C (cs)
HU (2)	HU206611B (cs)
IE (1)	IE63098B1 (cs)
IL (1)	IL89460A (cs)
MX (1)	MX170499B (cs)
MY (1)	MY104992A (cs)
NO (1)	NO178284C (cs)
NZ (1)	NZ228309A (cs)
PH (1)	PH25000A (cs)
PL (1)	PL160475B1 (cs)
RU (1)	RU2008915C1 (cs)
SE (1)	SE461313B (cs)
SK (1)	SK280244B6 (cs)
WO (1)	WO1989008441A1 (cs)
YU (1)	YU55389A (cs)
ZA (1)	ZA891818B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5540921A (en) *	1993-03-10	1996-07-30	Kose Corporation	Solid o/w-type cosmetic composition
US6300062B1 (en)	1995-07-13	2001-10-09	Biora Ab	Enamel matrix related polypeptide
WO1997002730A2 (en) *	1995-07-13	1997-01-30	Biora Ab	Enamel matrix related polypeptide
US5762502A (en) *	1996-07-11	1998-06-09	Bahn; Arthur N.	Process for adhering composites to human teeth
IL137869A0 (en) *	1998-02-27	2001-10-31	Biora Bioex Ab	Matrix protein compositions for wound healing
BRPI9908182C1 (pt)	1998-02-27	2021-05-25	Biora Ab	composições de proteína de matriz para cura de feridas
US6677306B1 (en)	1998-07-29	2004-01-13	Northwestern University	Chondrogenic and osteogenic inducing molecule
WO2000006734A1 (en) *	1998-07-29	2000-02-10	Northwestern University	Chondrogenic and osteogenic inducing molecule
ATE258442T1 (de) *	1999-03-10	2004-02-15	Biora Bioex Ab	Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben
US20030096740A1 (en)	1999-03-10	2003-05-22	Lars Hammarstrom	Matrix protein compositions for induction of apoptosis
JP5095063B2 (ja) *	2000-06-20	2012-12-12	ストローマンホールディングアーゲー	象牙質再生に用いる基質タンパク質組成物
US6899915B2 (en) *	2000-11-29	2005-05-31	President And Fellows Of Harvard College	Methods and compositions for culturing a biological tooth
KR100450146B1 (ko) *	2002-02-19	2004-09-30	정필훈	발치된 치아로부터 치아 단백질의 추출방법과 그의이용방법
JP4643932B2 (ja) *	2004-06-28	2011-03-02	花王株式会社	アメロゲニン融合タンパク質
WO2006019649A1 (en)	2004-07-15	2006-02-23	Dentigenix Inc.	Mineralizing composite materials for restoring teeth
SE0403014D0 (sv)	2004-12-10	2004-12-10	Straumann Holding Ag	New protein formulation
EP1830863A2 (en)	2004-12-10	2007-09-12	Straumann Holding AG	Protein formulation
US20060257492A1 (en) *	2005-05-13	2006-11-16	Depuy Products, Inc.	Suspension of calcium phosphate particulates for local delivery of therapeutic agents
WO2011051457A2 (en)	2009-11-02	2011-05-05	Straumann Holding Ag	Purified emd protein composition
WO2011073447A1 (en)	2009-12-18	2011-06-23	Straumann Holding Ag	Emd c-depleted
GB0922438D0 (en)	2009-12-22	2010-02-03	Ucl Business Plc	Agents having tissue generative activity
CN103403148A (zh)	2010-10-01	2013-11-20	纽约市哥伦比亚大学理事会	通过细胞产生牙本质、牙骨质和牙釉质
JP5671618B2 (ja)	2010-10-15	2015-02-18	ストラウマンホールディングアーゲー	Ｐｇａを含んでなる新しいｅｍｄ製剤
WO2012153333A1 (en)	2011-05-09	2012-11-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Regeneration and repair of mesenchymal tissue using amelogenin
US9957314B2 (en)	2011-05-09	2018-05-01	Hadasit Medical Research Services And Development Ltd.	Regeneration and repair of mesenchymal tissue using amelogenin
US11457996B2 (en)	2019-09-12	2022-10-04	King Abdulaziz University	Dental pulp capping composition and method of preserving and regenerating capped pulp and dentin bridge

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2220063A1 (de) *	1972-04-24	1973-11-08	Ministerul En Electrice	Implantat, seine herstellung und konditionierung
US3913229A (en) *	1974-02-25	1975-10-21	Miter Inc	Dental treatments
US4172128A (en) *	1975-03-26	1979-10-23	Erhard Thiele	Process of degrading and regenerating bone and tooth material and products
JPS6045602B2 (ja) *	1978-09-28	1985-10-11	正隆片桐	生物性移植体とその製作法
DE3127270A1 (de) *	1981-07-10	1983-03-24	Link, Gottlieb, 4950 Minden	Knochenersatz-implantat als grundlage fuer die einpflanzung eines kunstzahns
JPS595109A (ja) *	1982-06-30	1984-01-12	Lion Corp	口腔用組成物
US4801299A (en) *	1983-06-10	1989-01-31	University Patents, Inc.	Body implants of extracellular matrix and means and methods of making and using such implants
US4672032A (en) *	1983-11-09	1987-06-09	University Of Southern California	Dental enamel production
FR2569565B1 (fr) *	1984-08-31	1987-06-19	Russier Jean Jacques	Joint physiologique etanche pour implants endo-extracorporels
US4702734A (en) *	1986-05-08	1987-10-27	Meloy Laboratories, Inc.	Method of promoting periodontal regeneration and fibroblast bonding
SE454480B (sv) *	1986-09-25	1988-05-09	Lars Hammarstrom	Bindningsinducerande komposition

1988
- 1988-03-17 SE SE8800980A patent/SE461313B/sv not_active IP Right Cessation
- 1988-03-25 DD DD88314040A patent/DD281116A5/de not_active IP Right Cessation
- 1988-03-25 HU HU883310A patent/HU206611B/hu not_active IP Right Cessation
1989
- 1989-03-02 IL IL89460A patent/IL89460A/xx unknown
- 1989-03-09 ZA ZA891818A patent/ZA891818B/xx unknown
- 1989-03-09 PH PH38310A patent/PH25000A/en unknown
- 1989-03-13 NZ NZ228309A patent/NZ228309A/en unknown
- 1989-03-15 PL PL1989278257A patent/PL160475B1/pl unknown
- 1989-03-15 DD DD89326622A patent/DD283563A5/de unknown
- 1989-03-16 IE IE84689A patent/IE63098B1/en not_active IP Right Cessation
- 1989-03-16 CZ CS891637A patent/CZ284330B6/cs not_active IP Right Cessation
- 1989-03-16 DK DK198901280A patent/DK175731B1/da not_active IP Right Cessation
- 1989-03-16 SK SK1637-89A patent/SK280244B6/sk unknown
- 1989-03-16 ES ES89850090T patent/ES2055159T3/es not_active Expired - Lifetime
- 1989-03-16 DE DE8989850090T patent/DE68906455T2/de not_active Expired - Lifetime
- 1989-03-16 AU AU31405/89A patent/AU613161B2/en not_active Expired
- 1989-03-16 WO PCT/SE1989/000139 patent/WO1989008441A1/en not_active Ceased
- 1989-03-16 CA CA000593963A patent/CA1339338C/en not_active Expired - Lifetime
- 1989-03-16 HU HU892558A patent/HU203964B/hu unknown
- 1989-03-16 EP EP89850090A patent/EP0337967B1/en not_active Expired - Lifetime
- 1989-03-16 AT AT89850090T patent/ATE89156T1/de not_active IP Right Cessation
- 1989-03-16 JP JP1062348A patent/JP2795667B2/ja not_active Expired - Lifetime
- 1989-03-17 YU YU00553/89A patent/YU55389A/xx unknown
- 1989-03-17 MX MX015325A patent/MX170499B/es unknown
- 1989-03-17 KR KR1019890702137A patent/KR0175138B1/ko not_active Expired - Fee Related
- 1989-03-17 MY MYPI89000336A patent/MY104992A/en unknown
- 1989-03-17 CN CN89101581A patent/CN1034630C/zh not_active Expired - Lifetime
1990
- 1990-09-12 US US07/581,031 patent/US5071958A/en not_active Expired - Lifetime
- 1990-09-13 FI FI904521A patent/FI90011C/fi not_active IP Right Cessation
- 1990-09-14 NO NO904023A patent/NO178284C/no not_active IP Right Cessation
- 1990-09-17 RU SU904831270A patent/RU2008915C1/ru active
1991
- 1991-04-22 US US07/689,122 patent/US5098891A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0337967A2 (en)	1989-10-18
DD283563A5 (de)	1990-10-17
FI90011B (fi)	1993-09-15
MX170499B (es)	1993-08-26
HU203964B (en)	1991-11-28
ZA891818B (en)	1989-11-29
SE461313B (sv)	1990-02-05
DK128089D0 (da)	1989-03-16
NZ228309A (en)	1992-04-28
FI90011C (fi)	1993-12-27
CZ163789A3 (en)	1994-11-16
CN1034630C (zh)	1997-04-23
SK163789A3 (en)	1999-10-08
HU892558D0 (en)	1991-03-28
IL89460A0 (en)	1989-09-10
IL89460A (en)	1993-07-08
US5098891A (en)	1992-03-24
PH25000A (en)	1990-12-26
AU3140589A (en)	1989-09-21
IE63098B1 (en)	1995-03-22
ATE89156T1 (de)	1993-05-15
JP2795667B2 (ja)	1998-09-10
CZ284330B6 (cs)	1998-10-14
HUT58199A (en)	1992-02-28
US5071958A (en)	1991-12-10
ES2055159T3 (es)	1994-08-16
JPH0242022A (ja)	1990-02-13
DK175731B1 (da)	2005-02-07
DD281116A5 (de)	1990-08-01
YU55389A (en)	1991-06-30
EP0337967A3 (en)	1990-05-16
KR900700073A (ko)	1990-08-11
RU2008915C1 (ru)	1994-03-15
DK128089A (da)	1989-12-04
DE68906455T2 (de)	1993-09-09
CA1339338C (en)	1997-08-19
SE8800980L (sv)	1989-09-18
NO904023L (no)	1990-11-12
PL160475B1 (pl)	1993-03-31
HUT54884A (en)	1991-04-29
PL278257A1 (en)	1989-10-30
NO178284C (no)	1996-02-28
WO1989008441A1 (en)	1989-09-21
FI904521A0 (fi)	1990-09-13
DE68906455D1 (de)	1993-06-17
AU613161B2 (en)	1991-07-25
HU206611B (en)	1992-12-28
IE890846L (en)	1989-09-17
NO904023D0 (no)	1990-09-14
EP0337967B1 (en)	1993-05-12
KR0175138B1 (ko)	1999-02-01
CN1035773A (zh)	1989-09-27
NO178284B (no)	1995-11-20
MY104992A (en)	1994-07-30
SE8800980D0 (sv)	1988-03-17

Publication	Publication Date	Title
SK280244B6 (sk)	1999-10-08	Kompozícia na použitie pri indukcii spojenia medzi
JP3101739B2 (ja)	2000-10-23	天然の骨組織から骨形成術のための材料を製造する方法及びこれによって得られた材料
AU602165B2 (en)	1990-10-04	Binding-inducing composition
AU593094B2 (en)	1990-02-01	Marrow/collagen/mineral matrix for bone defect repair
Timmel et al.	1982	The interposition of Lyodura in operations for ankylosis of the temporo-mandibular joint: an experimental study using pigs
FI91216B (fi)	1994-02-28	Menetelmä sitoutumista indusoivan koostumuksen valmistamiseksi
CZ193588A3 (cs)	1999-04-14	Prostředek pro regeneraci mineralizované tkáně a způsob jeho výroby
PL154615B1 (pl)	1991-08-30	Sposób otrzymywania matrycy szkliwa
IE60098B1 (en)	1994-06-01	Binding-inducing composition
Skinner	1975	Collagen and chondroitin sulfate xenogeneic implants in primates: a sequential histopathologic study